NDC11 31722088832
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 31722-0888-32 | 31722-0888 |
| 31722-888-32 | 31722-888 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olmesartan medoxomil and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | d421f352-9500-4d3e-8bc3-0cdcc2050514 | 2025-08-26 | Boxed warning, Warnings, Adverse reactions | 31722-888-32 31722-888 31722088832 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.